State
72,982 recalls have nationwide distribution and so reach Vermont. 1,983 additional recalls listed Vermont specifically in their distribution scope.
Of the 1,983 recalls naming Vermont we have scored against our rubric, 199 (10%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 409 (21%) are Severe.
Which agencies issued them
These figures cover only the 1,983 recalls whose distribution notice names Vermont specifically. The 72,982 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
Glenmark Pharmaceuticals Inc. is voluntarily recalling Teriflunomide 14mg tablets (Lot #17232462, expiring Nov-25) distributed nationwide due to current good manufacturing practice (CGMP) deviations discovered during production.
Glenmark Pharmaceuticals Inc., USA is voluntarily recalling Fluphenazine Hydrochloride Tablets 2.5mg nationwide due to Current Good Manufacturing Practice (CGMP) deviations. The affected lot is 17232214 with expiration date September 2025.
Glenmark Pharmaceuticals is recalling Ranolazine Extended-Release 1000mg tablets (Lot 17240040) nationwide due to manufacturing deviations. This is a voluntary, firm-initiated recall.
Glenmark Pharmaceuticals is recalling Saxagliptin 2.5mg tablets nationwide due to manufacturing quality issues. The firm initiated this voluntary recall on March 13, 2025.
Asegua Therapeutics is recalling 18,541 cartons of Sofosbuvir and Velpatasvir tablets nationwide due to defective blister packs that are not properly sealed, resulting in loose tablets in cartons. No illnesses or injuries have been reported.
Glenmark Pharmaceuticals Inc. is recalling Pravastatin Sodium 20mg tablets nationwide due to Current Good Manufacturing Practice (CGMP) deviations. The recall affects specific lot numbers distributed across the U.S.
Glenmark Pharmaceuticals Inc., USA is voluntarily recalling Lacosamide Tablets 50mg due to Current Good Manufacturing Practice (CGMP) deviations. The recall affects specific lots distributed nationwide.
Glenmark Pharmaceuticals Inc. is recalling Propafenone Hydrochloride Extended-Release Capsules 325mg (Lot #17230767, expiring Mar-25) distributed nationwide due to current Good Manufacturing Practice (CGMP) deviations. Patients taking this medication should consult their physician before discontinuing use.
Glenmark Pharmaceuticals Inc., USA is voluntarily recalling Pravastatin Sodium Tablets, USP, 20mg, 90-count bottles (Lot # 17230810, expiration Mar-26) nationwide due to manufacturing process deviations.
Glenmark Pharmaceuticals Inc. is recalling Colesevelam Hydrochloride 625mg tablets nationwide due to CGMP deviations. The firm initiated this Class II voluntary recall; no illnesses or injuries have been reported.
Glenmark Pharmaceuticals is voluntarily recalling Saxagliptin 5mg tablets nationwide due to CGMP deviations. Affected lot numbers are 17232460 and 17241194.
Glenmark Pharmaceuticals Inc. USA is recalling Voriconazole Tablets 50mg (Lot # 17231045, exp. date Apr-25) distributed nationwide due to Current Good Manufacturing Practice (CGMP) deviations identified during manufacturing.
Glenmark Pharmaceuticals Inc. USA is recalling Clindamycin Hydrochloride Capsules, USP 300mg due to CGMP deviations. The product has been distributed nationwide.
Glenmark Pharmaceuticals is voluntarily recalling Indomethacin Extended-Release Capsules (75mg) distributed nationwide due to Good Manufacturing Practice deviations identified during FDA oversight.
Glenmark Pharmaceuticals is recalling Rufinamide 200mg tablets nationwide due to manufacturing process deviations. The voluntary recall affects certain lot numbers with July 2025 expiration dates.
Sun Pharmaceutical Industries Inc. is recalling Gabapentin Capsules 400 mg due to cross contamination. The recall affects 852 bottles distributed nationwide.
Sun Pharmaceutical Industries is recalling Gabapentin Capsules, USP 300 mg, due to cross contamination. The recall affects approximately 12,876 bottles distributed nationwide.
Chrysler is recalling certain 2023-2025 Alfa Romeo Tonale and Dodge Hornet vehicles because the display module may not show the rearview camera image, failing FMVSS 111.
Audi is recalling 2022-2023 RS E-TRON GT and E-TRON GT vehicles because a wiring fault may deactivate the front passenger air bag, increasing injury risk in a crash.
Goodyear is recalling specific Cooper Discoverer Stronghold AT tires because they lack the required week and year code. This prevents owners from determining the tire's age or recall status.
Prevost is recalling 2025 H3-45 and X3-45 motorcoaches because emergency exit windows may be difficult to open, increasing injury risk.
Nova Bus is recalling specific ZF brake chambers sold as replacement parts for buses because improper manufacturing may cause air leaks, increasing the risk of unexpected braking, overheating, or fire.
Maserati is recalling 2024 Granturismo vehicles because the tire label may detach, potentially leading to vehicle overload and increased crash risk.
Oshkosh is recalling 216 model-year 2025 NGDV vehicles because the rearview camera image may not display in reverse, increasing crash risk.
Forest River is recalling certain 2024-2025 trailers with a removable step assembly because the clip-on bracket mounting bolt may allow the steps to detach in use.